StatPearls, LLC

  • Antifungal Agents
  • Meningitis, Cryptococcal

Antifungal Agents

Fungi are eukaryotic organisms found in nearly every environment, with only a limited subset contributing to human disease. These pathogenic fungi can cause infections ranging from mild cutaneous conditions to invasive, life-threatening diseases such as cryptococcal meningitis. Antifungal agents serve as a critical therapeutic class for managing these infections. Understanding the pharmacologic characteristics of antifungal medications including spectrum of activity, mechanism of action, and pharmacokinetics is essential for effective treatment selection. This activity provides healthcare professionals with essential information on antifungal resistance trends, clinical guidelines for treating superficial and systemic fungal infections, and therapeutic considerations for high-risk populations, including the immunocompromised. Emphasis is placed on strategies for clinical decision-making, monitoring for efficacy and toxicity, and recognizing drug-drug interactions and adverse effect profiles. The role of emerging antifungal therapies and evolving patterns in fungal epidemiology is also discussed. This activity supports improved patient outcomes through informed prescribing and management of antifungal agents.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABOS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABA — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABOHNS — Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 13 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left